CDKN3 and cervical carcinoma: Several histological studies have reported the application of most common cellular biomarkers, including Ki-67, cyclin-dependent kinase inhibitor (p16), and ProEx C [topoisomerase II-alpha (TOP2A) and minichromosomal maintenance-2 (MCM2)] in the early diagnosis of cervical cancer [14–17].